Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis

Lignende værker

• Combination Therapy With Tofacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction Therapy for Refractory Ulcerative Colitis
  af: Tanida, Satoshi, et al.
  Udgivet: (2020)
• Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn's Disease
  af: Ozeki, Keiji, et al.
  Udgivet: (2012)
• Long-Term Efficacy of Adalimumab in Patients With Intestinal Behcet’s Disease: Eight Consecutive Cases
  af: Tanida, Satoshi, et al.
  Udgivet: (2016)
• Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to Infliximab
  af: Mizoshita, Tsutomu, et al.
  Udgivet: (2016)
• Advances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2
  af: Tanida, Satoshi, et al.
  Udgivet: (2015)